Atlas Trials

Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device

Clinical trial NCT02018172 · TERMINATED

Trial details

NCT number
NCT02018172
Sponsor
Ferring Pharmaceuticals
Status
TERMINATED
Study type
OBSERVATIONAL
Growth Hormone DeficiencyTurner's Syndrome
Start date
2014-07-01
Primary completion
2015-02-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.